Innovative pharmaceutical research facilitated by AI

Feng Zhu; Caisheng Wu; Tingjun Hou

doi:10.1016/j.jpha.2025.101388

Volume 15 Issue 6

Jun. 2025

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2025 > 15(6): 101388

Feng Zhu, Caisheng Wu, Tingjun Hou. Innovative pharmaceutical research facilitated by AI[J]. Journal of Pharmaceutical Analysis, 2025, 15(6): 101388. doi: 10.1016/j.jpha.2025.101388

Citation:

Feng Zhu, Caisheng Wu, Tingjun Hou. Innovative pharmaceutical research facilitated by AI[J]. Journal of Pharmaceutical Analysis, 2025, 15(6): 101388. doi: 10.1016/j.jpha.2025.101388

Feng Zhu, Caisheng Wu, Tingjun Hou. Innovative pharmaceutical research facilitated by AI[J]. Journal of Pharmaceutical Analysis, 2025, 15(6): 101388. doi: 10.1016/j.jpha.2025.101388

Citation:

Feng Zhu, Caisheng Wu, Tingjun Hou. Innovative pharmaceutical research facilitated by AI[J]. Journal of Pharmaceutical Analysis, 2025, 15(6): 101388. doi: 10.1016/j.jpha.2025.101388

PDF( 435 KB)

Innovative pharmaceutical research facilitated by AI

doi: 10.1016/j.jpha.2025.101388

a. College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China;
b. Fujian Provincial Key Laboratory of Innovative Drug Target Research and State Key Laboratory of Cell Stress Biology, School of Pharmaceutical Sciences, Xiamen University, Xiamen, 361102, China;
c. College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, 310058, China

Available Online: Jul. 18, 2025
Publish Date: Jul. 15, 2025

Abstract

FullText(HTML)

References(21)

References

[1]	M.W. Mullowney, K.R. Duncan, S.S. Elsayed, et al., Artificial intelligence for natural product drug discovery, Nat Rev Drug Discov 22 (2023) 895-916.
[2]	Z. Chen, X. Zhao, H. Zheng, et al., Advances and challenges in drug design against dental caries: Application of in silico approaches, Journal of Pharmaceutical Analysis 15 (2025) 101161.
[3]	J. Wang, P. Zhou, Z. Wang, et al., Diffusion-based generative drug-like molecular editing with chemical natural language, Journal of Pharmaceutical Analysis 15 (2025) 101137.
[4]	W. Xiao, M. Zhang, D. Zhao, et al., TCMKD: From ancient wisdom to modern insights-A comprehensive platform for traditional Chinese medicine knowledge discovery, Journal of Pharmaceutical Analysis 15 (2025) 101297.
[5]	J. Jiang, L. Chen, L. Ke, et al., A review of transformer models in drug discovery and beyond, Journal of Pharmaceutical Analysis 15 (2025) 101081.
[6]	A. Sen, P.S. Mohanraj, V. Laxmi, et al., Advancement of artificial intelligence based treatment strategy in type 2 diabetes: A critical update, Journal of Pharmaceutical Analysis 15 (2025) 101305.
[7]	Z.-X. Zhou, H.-X. Zhang, Q. Zheng, Generation of SARS-CoV-2 dual-target candidate inhibitors through 3D equivariant conditional generative neural networks, Journal of Pharmaceutical Analysis 15 (2025) 101229.
[8]	J. Mei, F. Jiao, Y. Li, et al., Application of thrombopoietic agents in cancer therapy-induced thrombocytopenia: A comprehensive review, Blood Reviews 70 (2025) 101257.
[9]	D. Xiong, Y. Ming, Y. Li, et al., EvoNB: A protein language model-based workflow for nanobody mutation prediction and optimization, Journal of Pharmaceutical Analysis 15 (2025) 101260.
[10]	Y. Hu, F. Tao, J. Xu, et al., Combining transformer and 3DCNN models to achieve co-design of structures and sequences of antibodies in a diffusional manner, Journal of Pharmaceutical Analysis 15 (2025) 101267.
[11]	Y. Cun, H. Ding, T. Mao, et al., SITA: Predicting site-specific immunogenicity for therapeutic antibodies, Journal of Pharmaceutical Analysis 15 (2025) 101316.
[12]	K. Li, B. Shen, F. Feng, et al., A disentangled generative model for improved drug response prediction in patients via sample synthesis, Journal of Pharmaceutical Analysis 15 (2025) 101128.
[13]	C. Yuan, D. Zhang, H. Zhang, et al., Breaking barriers: MS-BDF tools in the quality control of insect-derived traditional Chinese medicine, Journal of Pharmaceutical Analysis 15 (2025) 101193.
[14]	J. Zhang, M. Zhang, W. Huang, et al., Scaffold and SAR studies on c-MET inhibitors using machine learning approaches, Journal of Pharmaceutical Analysis 15 (2025) 101303.
[15]	Y. Lu, Z. Zhou, Q. Li, et al., Perturbation response scanning of drug-target networks: Drug repurposing for multiple sclerosis, Journal of Pharmaceutical Analysis 15 (2025) 101295.
[16]	Y. Yan, Y. Yang, Z. Tong, et al., Adaptive multi-view learning method for enhanced drug repurposing using chemical-induced transcriptional profiles, knowledge graphs, and large language models, Journal of Pharmaceutical Analysis 15 (2025) 101275.
[17]	J. Li, Y. Zhao, Z. Wang, et al., Identify drug-drug interactions via deep learning: A real world study, Journal of Pharmaceutical Analysis 15 (2025) 101194.
[18]	M. Mou, Y. Zhang, Y. Qian, et al., druglikeFilter 1.0: An AI powered filter for collectively measuring the drug-likeness of compounds, Journal of Pharmaceutical Analysis 15 (2025) 101298.
[19]	C. Yang, C. Gong, Z. Zhang, et al., In silico prediction of pKa values using explainable deep learning methods, Journal of Pharmaceutical Analysis 15 (2025) 101174.
[20]	S. Liu, M. Chen, X. Yao, et al., Fingerprint-enhanced hierarchical molecular graph neural networks for property prediction, Journal of Pharmaceutical Analysis 15 (2025) 101242.
[21]	Y. Jia, X. Liang, L. Zhang, et al., Machine learning-assisted microfluidic approach for broad-spectrum liposome size control, Journal of Pharmaceutical Analysis 15 (2025) -101221.